抄録
The present study was undertaken to characterize the transport of (3-methyl-His2) thyrotropin-releasing hormone ([3H]MeTRH) across the blood-brain barrier in mice and the effects of thyrotropin-releasing hormone (TRH) and its analogues (taltirelin and montirelin) on the transport and brain distribution. Integration plot analysis was used to calculate the influx clearance (CLin) of [3H]MeTRH after intravenous (i.v.) injection in mice. Furthermore, the capillary depletion method was performed to determine whether [3H]MeTRH crossed the blood-brain barrier. The effects of TRH and its analogues on the brain distribution of [3H]MeTRH were also examined by co-injection with the radioligand. The brain distribution of [3H]MeTRH and [14C]sucrose increased with the time after i.v. injection in mice, and the level of [3H]MeTRH was significantly higher than that of [14C]sucrose 5 min after the injection. The CLin value of [3H]MeTRH was significantly higher than that of [14C]sucrose, and the value of [3H]MeTRH was reduced by co-injection with unlabeled MeTRH. Also, capillary depletion showed that [3H]MeTRH was distributed largely in the brain parenchyma and this distribution was significantly inhibited by co-injection of TRH and montirelin but not taltirelin. The present study indicates that the transport of [3H]MeTRH into the brain may be via a saturable process.